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Unlike their descendants, mitochondria and plastids, bacteria do
not have dedicated protein import systems. However, paradoxi-
cally, import of protein bacteriocins, the mechanisms of which are
poorly understood, underpins competition among pathogenic and
commensal bacteria alike. Here, using X-ray crystallography, iso-
thermal titration calorimetry, confocal fluorescence microscopy,
and in vivo photoactivatable cross-linking of stalled translocation
intermediates, we demonstrate how the iron transporter FpvAI in
the opportunistic pathogen Pseudomonas aeruginosa is hijacked
to translocate the bacteriocin pyocin S2 (pyoS2) across the outer
membrane (OM). FpvAI is a TonB-dependent transporter (TBDT) that
actively imports the small siderophore ferripyoverdine (Fe-Pvd) by
coupling to the proton motive force (PMF) via the inner membrane
(IM) protein TonB1. The crystal structure of the N-terminal domain
of pyoS2 (pyoS2NTD) bound to FpvAI (Kd = 240 pM) reveals that the
pyocin mimics Fe-Pvd, inducing the same conformational changes in
the receptor. Mimicry leads to fluorescently labeled pyoS2NTD being
imported into FpvAI-expressing P. aeruginosa cells by a process
analogous to that used by bona fide TBDT ligands. PyoS2NTD induces
unfolding by TonB1 of a force-labile portion of the plug domain that
normally occludes the central channel of FpvAI. The pyocin is then
dragged through this narrow channel following delivery of its own
TonB1-binding epitope to the periplasm. Hence, energized nutrient
transporters in bacteria also serve as rudimentary protein import
systems, which, in the case of FpvAI, results in a protein antibiotic
60-fold bigger than the transporter’s natural substrate being trans-
located across the OM.
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Bacteriocins are peptide or protein antibiotics produced bybacteria to kill their neighbors, usually in response to envi-
ronmental stress, that play a fundamental role in shaping bacterial
communities (1–3) and are implicated in the invasion mechanisms
of pathogens (4, 5). Bacteriocins are currently the focus of in-
tense efforts to develop them as much needed antibiotics against
multidrug-resistant bacteria (6, 7) and as antiinfectives for use in
agriculture (8). The present work centers on the mode of action of
protein bacteriocins, which are species-specific protein antibiotics
that are widespread agents of competition in gram-negative bac-
teria (9). Protein bacteriocins are known to parasitize a variety of
cell envelope proteins (10), but how they exploit these systems to
promote their import has remained unresolved since their dis-
covery (11). We reveal the mechanism by which the nuclease
bacteriocin pyocin S2 (pyoS2) crosses the outer membrane (OM)
of Pseudomonas aeruginosa, a path that is likely to be used by
other TonB-dependent protein bacteriocins.
Protein bacteriocins are 40- to 80-kDa toxins that carry a
single cytotoxic domain at their C terminus into the cell. Cell
death ensues through depolarization of the cell by an ionophore
or enzymatic cleavage of peptidoglycan precursors in the peri-
plasm or nucleic acids (DNA, tRNA, or rRNA) in the cytoplasm
(12). The best studied of the protein bacteriocins are the colicins
that target and kill Escherichia coli. Colicins exploit a variety of
OM proteins as their primary receptor, including the vitamin B12
transporter BtuB and the siderophore transporter FepA (13, 14).
Colicin entry into cells requires contact with proton motive force
(PMF)-linked systems in the inner membrane (IM) that span the
periplasm: Tol-Pal for group A colicins and Ton for group B
colicins (15). Tol-Pal is a multiprotein complex involving three
IM proteins (TolA, TolQ, and TolR), a periplasmic protein
(TolB), and an OM lipoprotein (Pal). The Ton system comprises
three IM proteins (TonB, ExbB, and ExbD). Both systems, which
are virulence factors in pathogenic bacteria, energize processes
at the OM: Tol-Pal stabilizes the membrane, while Ton catalyzes
import of scarce nutrients such as iron and vitamins across the
membrane. Group A colicins generally require additional OM
proteins, usually porins, to contact the Tol-Pal system (16). Few
translocator proteins have been identified for group B colicins
(10). How the Ton or Tol-Pal system catalyzes import of a
protein bacteriocin across the OM is unknown. Once in the
periplasm, nuclease colicins are translocated across the IM by
the AAA+ ATPase FtsH, which also proteolytically releases the
nuclease domain to the cytoplasm (17, 18). In the present work,
we reveal how pyoS2, a Ton-dependent protein bacteriocin,
translocates across the OM through its receptor and show that
this mechanism has strong parallels with that used by the en-
dogenous ligand for the receptor.
Significance
The outer membrane (OM) excludes antibiotics such as vanco-
mycin that kill gram-positive bacteria, and so is a major con-
tributor to multidrug resistance in gram-negative bacteria. Yet,
the OM is readily bypassed by protein bacteriocins, which are
toxins released by bacteria to kill their neighbors during com-
petition for resources. Discovered over 60 y ago, it has been a
mystery how these proteins cross the OM to deliver their toxic
payload. We have discovered how the bacteriocin pyocin S2
(pyoS2), which degrades DNA, enters Pseudomonas aeruginosa
cells. PyoS2 tricks the iron transporter FpvAI into transporting it
across the OM by a process that is remarkably similar to that
used by its endogenous ligand, the siderophore ferripyoverdine.
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Results
The N-Terminal Domain of PyoS2 Mimics Ferripyoverdine Binding to
FpvAI. PyoS2 is a 74-kDa endonuclease bacteriocin that is ef-
fective in the treatment of P. aeruginosa-induced pneumonia in
mice and in eradicating P. aeruginosa biofilms (6, 19). The pri-
mary receptor for pyoS2 is FpvAI (20–22), a TonB-dependent
transporter (TBDT) (23) that actively imports ferripyoverdine
(Fe-Pvd) (24). FpvAI is a classical 22-stranded β-barrel with a
central channel that is completely occluded by a globular “plug”
domain, which must be reconfigured for substrate transport by
coupling to the PMF via TonB1 (25).
Our starting point for elucidating the pyoS2 mechanism of
entry was to delineate the FpvAI-binding domain by limited
trypsin digestion (residues 1–209; Materials and Methods). The
isolated 23-kDa N-terminal domain of pyoS2 (pyoS2NTD) was
folded (Fig. S1A) and outcompeted Fe-Pvd for FpvAI (Fig. 1A),
which it bound with high affinity in competition isothermal ti-
tration calorimetry (ITC) experiments (Kd = 240 pM) (Fig. 1B).
We solved the crystal structure of the FpvAI–pyoS2NTD complex
by molecular replacement to a resolution of 2.8 Å (details are
provided in Materials and Methods). Continuous electron density
was observed for residues 11–208 of the pyoS2NTD, and near-
complete density was observed for FpvAI (Fig. 1C and Table S1).
PyoS2NTD is composed of five α-helices, including a C-terminal
helix extending ∼80 Å from the interface and a short antiparallel
β-hairpin at the N terminus (residues 11–26) that docks onto the
helical bundle. Spectroscopic measurements indicated that this
N-terminal region is folded in solution and contributes to the
stability of the domain, but high B-factors in the crystal structure
suggest this region is likely to be dynamic (Fig. S1). An 11-amino
acid proline-rich region (PRR; residues 35–45) contacts pri-
marily the FpvAI plug domain. Deletion of the first 45 residues,
including the PRR (Δ1–45 pyoS2NTD), decreased pyoS2NTD
binding ∼1,000-fold (Fig. S2). Importantly, the PRR not only
occupies the same binding site as Fe-Pvd but also resembles its
shape (Fig. 1 D and E and Fig. S3A). Consequently, pyoS2NTD
induces conformational changes within the plug that are very
similar to those triggered by Fe-Pvd, as evidenced by comparable
backbone rmsds for the two complexes relative to unliganded
receptor and by the equivalent reconfiguring of the same sec-
ondary structure elements (Fig. S3 B–E). In summary, the
structure of the complex points to pyoS2 exploiting FpvAI both
as a receptor and translocator, in contrast to bacteriocins that
recruit additional OM proteins for import (3).
PyoS2NTD Translocates into P. aeruginosa Cells. We developed a
fluorescence-based assay using Alexa Fluor 488-conjugated
pyoS2NTD (pyoS2NTD-AF488) to probe pyoS2NTD import in vivo.
Addition of pyoS2NTD-AF488 to live P. aeruginosa PAO1 cells
yielded fluorescent bacteria, whereas those lacking FpvAI were
not labeled (Fig. 2A). Fluorescence recovery after photobleaching
(FRAP) was used to monitor pyoS2NTD-AF488 translocation. Since
OM proteins have restricted lateral diffusion (26), the expectation
was that pyoS2NTD-AF488 bound to FpvAI would not show fluo-
rescence recovery in FRAP experiments. Instead, we observed rapid
fluorescence recovery (Fig. 2B), suggesting pyoS2NTD-AF488 was
translocating to the periplasm, where it could diffuse freely. We
investigated the energetics of import as a test of this hypothesis.
Dissipation of the PMF by the addition of the protonophore car-
bonyl cyanide m-chlorophenyl hydrazone (CCCP) to P. aeruginosa
before labeling with pyoS2NTD-AF488 resulted in no recovery of
fluorescence in FRAP experiments (Fig. 2C), consistent with
pyoS2NTD-AF488 remaining bound to FpvAI in the OM of a
deenergized cell. TBDT ligands are transported through their re-
ceptors in conjunction with the PMF, which is transduced into
mechanical force by engagement of the IM protein TonB with a
TonB box motif of the transporter (23) (Fig. 1C). The TonB box of
FpvAI is known to be required for both Fe-Pvd import and
pyoS2 toxicity (27). Of the three tonB genes in P. aeruginosa, only
tonB1 was required for pyoS2 toxicity (Fig. S4A), as has been
reported for Fe-Pvd import (28). We also identified a putative TonB
box at the N terminus of pyoS2NTD (M11VITH15) that comprises the
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Fig. 1. High-affinity binding of pyoS2NTD to FpvAI mimics that of Fe-Pvd.
(A) PyoS2NTD outcompetes Fe-Pvd for FpvAI binding in analytical gel-filtration
chromatography. Protein elution was monitored at A280 (solid line), and Fe-
Pvd elution was monitored at A400 (dashed line). mAu, milliabsorbance units.
(B) ITC data for pyoS2NTD binding FpvAI in the presence of a lower affinity
competitor, Δ1–45 pyoS2NTD (details are provided in Materials and Meth-
ods). Data from two independent experiments were fitted to a competitive
binding model from which the following thermodynamic parameters were
extracted: ΔH = −15.8 ± 1.4 kcal/mol, ΔS = −9.1 ± 4.6 cal·mol−1·K−1, n =
0.78 ± 0.02 sites, Kd = 0.24 ± 0.004 × 10
−9 M. (C) The 2.8-Å crystal structure of
pyoS2NTD (blue) in complex with FpvAI (gray) highlighting the pyoS2NTD
β-hairpin (yellow), the FpvAI plug (brown) and signaling domains (black),
and the TonB1 box (red). Several of the β-strands that make up the β-barrel
of FpvAI have been removed to highlight the plug domain. The signaling
domain of FpvAI is involved in activating its own expression and that of Pvd
(41). (D and E) Comparison of FpvAI plug domain surface when bound by the
PRR of pyoS2NTD and Fe-Pvd, respectively, highlighting the movement of
FpvAI Tyr231 from its position in the unliganded state (light blue).
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first β-strand of the β-hairpin. TonB-dependent bacteriocins such
as colicin B, which targets E. coli, generally have their own TonB
box (29). Direct binding of pyoS2NTD to TonB1 was shown by ITC
(Kd ∼ 1 μM), as well as by cross-linking, and was abolished when the
β-hairpin was deleted (Δ1–30 pyoS2NTD) (Fig. S4 B–D). Deletion of
the TonB1 box (Δ1–21 pyoS2NTD-AF488) also abolished fluores-
cence recovery in FRAP experiments, as well as pyoS2 cytotoxicity
(Fig. S5 A and B). Finally, Δ1–21 pyoS2NTD-AF488 fluorescence,
when bound to cells, was completely removed by trypsin treat-
ment, in contrast to pyoS2NTD-AF488 (Fig. S5 C–E). We conclude
that as well as being the receptor-binding domain for the bacteriocin,
pyoS2NTD carries all of the information necessary for translocation
across the OM and that the process requires at least FpvAI, the
PMF, and TonB1 in the IM. Thereafter, import to the cytoplasm is
mediated by the bacteriocin nuclease domain FtsH and a conserved
DPY motif present in all nuclease bacteriocins (9, 17, 30).
PyoS2NTD Translocation Through FpvAI Mirrors That of a TBDT Ligand.
We developed a cross-linking strategy to map the pyoS2 import
route that capitalized on its PMF dependence and involved trapping
pyoS2NTD during translocation. The PMF delivers ∼20 pN me-
chanical force (31), and so we fused pyoS2NTD to GFP (pyoS2NTD-
GFP), which can resist up to 100 pN (32). In contrast to pyoS2NTD-
AF488, FRAP experiments with pyoS2NTD-GFP bound to P.
aeruginosa cells did not show fluorescence recovery, consistent with
a block in translocation (Fig. 3A). We substituted 13 pyoS2NTD resi-
dues, distributed throughout the pyoS2NTD-GFP construct, for the
UV-inducible cross-linker para-Benzoylphenylalanine (pBpa)
(Materials and Methods and Fig. 3B). The interfacial site
Tyr46pBpa was included as a positive control. All pBpa variants
were purified and first complexed with FpvAI in vitro. Of the
13 variants, cross-linking was only observed for Tyr46pBpa, its
cross-link to FpvAI Met431 at the protein–protein interface
confirmed by liquid chromatography-tandem mass spectrome-
try (LC-MS/MS) (Fig. S6). After ensuring pBpa labeling did not
interfere with pyoS2 cytotoxicity (Fig. S4E), we developed a
method for cross-linking and purifying pyoS2NTD-GFP trans-
location intermediates from live P. aeruginosa cells and iden-
tified cross-linking sites by LC-MS/MS (Materials and Methods).
In vivo cross-links were observed for all 13 pBpa variants,
suggesting that translocation intermediates were indeed trap-
ped by this strategy (Fig. 3C). We were able to map cross-links
for seven pBpa sites (Gln17, Ile23, Ala29, Lys70, Ala87,
Gln135, and Gln184), all of which were to transmembrane re-
gions of FpvAI that are inaccessible to pyoS2NTD in its ground
state complex with FpvAI (Fig. 1C). PyoS2NTD must translocate
significant distances to satisfy the cross-linking data, as in the
case of pyoS2NTD Gln184, which moves 76 Å to meet FpvAI
Val197 (Fig. 3 B–D). We identified six principal cross-link sites
in FpvAI, although LC-MS/MS data suggested residues to either
side of these sites are also hit, but at lower frequency (Figs. S7 and
S8). Five of six residues are within the plug domain that occludes
the channel, and one was to the barrel wall (Met766) (Fig. 3B).
Four pBpa sites (Gln17, Ile23, Ala87, and Gln135) cross-link to
the same FpvAI plug domain residue, Met177, suggesting much
of the pyoS2NTD polypeptide chain translocates past this residue.
We have interpreted our cross-linking data in the context of
recent atomic force microscopy (AFM) studies on other TBDTs,
the vitamin B12 transporter BtuB, and the ferric hydroxamate
receptor FhuA from E. coli (Fig. 4). Hickman et al. (33) have
shown that the plug domains of BtuB and FhuA are composed of
force-resistant and force-labile subdomains. Displacement of the
force-labile subdomain by engagement of TonB with the ligand-
bound transporter opens an ∼13-Å-wide channel. Structural
alignment of the plug domains of BtuB (34) and FpvAI identifies
an equivalent force-labile subdomain (Fig. S9). PyoS2NTD
translocation therefore involves at least three steps (Fig. 4). Step
1 is binding of pyoS2NTD to FpvAI, where Fe-Pvd mimicry in-
duces recruitment of TonB1 in the periplasm. Step 2 is PMF-
driven unfolding of the FpvAI force-labile subdomain, release of
the N-terminal β-hairpin, and delivery of the pyocin’s TonB1 box
through the channel, where it engages either the same or another
copy of TonB1. The pBpa substitutions at pyoS2NTD residues
Gln17, Ile23, and Ala29 all cross-link to sites within the channel,
either to the nonlabile subdomain (Asp239) or to the barrel wall
(Met766). Displacement of the β-hairpin from the helical bundle
of pyoS2NTD destabilizes the domain (Fig. S1C), expediting im-
port. Step 3 is TonB1-dependent unfolding of pyoS2NTD. The
majority of observed cross-links are for this final state in which five
pyoS2NTD residues spanning >100 amino acids become cross-
linked to three hyperreactive FpvAI labile subdomain residues
(Pro166, Met177, and Leu182). PyoS2NTD residues Gln17 and
Ile23 are among the sites that cross-link to FpvAI Met177, which,
along with their cross-links to Met776, explains why these residues
give two cross-linked adducts on SDS/PAGE (Fig. 3C). Finally, a
single cross-link was observed between pyoS2NTD Gln184pBpa
and FpvAI Val197, likely denoting the entrapment by GFP of the
translocating pyocin within the FpvAI channel.
Discussion
Our data show that PMF-coupled TonB1 imports pyoS2NTD by
dragging it through a narrow channel in FpvAI created by
TonB1-induced displacement of the labile plug subdomain, a
pathway ordinarily used by its ligand Fe-Pvd. TBDT plug dis-
placement is thought to be facilitated by waters at the plug–
barrel interface, which could lubricate pyoS2 translocation (35).
Two mechanisms seem reasonable as to how the remaining
∼500 amino acids of pyoS2 translocate through FpvAI; either the
PMF continues to be involved or refolding of pyoS2NTD in the
periplasm provides the driving force. Force-dependent unfolding of
PyoS2NTD-
AF488
B
C
PyoS2NTD-
AF488 + CCCP
Brightfield Pre-bleach Bleach
(t=0 mins)
Post-bleach
(t=2 mins)
PAO1
fpvAI+
PW5036
fpvAI−
A Brightfield Fluorescence
Fig. 2. PyoS2NTD translocates across the P. aeruginosa OM. (A) Fluorescence
labeling of live FpvAI-expressing P. aeruginosa PAO1 with pyoS2NTD-AF488.
The PAO1 fpvA− transposon mutant PW5036 (fpvA-H02::ISlacZ/hah) exhibits
no labeling. (Scale bars, 5 μm.) FRAP experiments on P. aeruginosa
PAO1 labeled with pyoS2NTD-AF488 (B) and pyoS2NTD-AF488 (C) are shown,
where cells were first treated with 100 μM CCCP. The bleached region is
highlighted (dashed circle). The absence of FRAP in these experiments sug-
gests pyoS2NTD remains bound to FpvAI in the OM, whereas FRAP suggests
pyoS2NTD-AF488 has translocated to the periplasm, where it can diffuse
laterally. (Scale bars, 1 μm.)
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the bacteriocin during import disrupts the high-affinity complexes
of the pyocin with FpvAI (Kd ’ pM) and the C-terminal nuclease
with its immunity protein (Kd ’ fM) (36). Immunity proteins
protect nuclease bacteriocin-producing cells but are displaced at
the cell surface during import (37). AFM studies have shown that
force-dependent remodeling of a colicin nuclease accelerates the
immunity protein dissociation rate (31). PyoS2 unfolding during
import could provide this remodeling force. Ton-dependent bac-
teriocins are widely distributed in bacteria, delivering different
cytotoxic activities (nucleases, peptidoglycan hydrolases, and ion-
ophores) (12). The subversion of FpvAI by pyoS2 demonstrates a
mechanism that is likely to be the basis of import for many Ton-
dependent bacteriocins and reveals how TBDTs moonlight as
protein transporters.
The protein import mechanism we have uncovered in bacteria
has similarities to the classical protein import pathway of mito-
chondria catalyzed by the translocase at outer membrane com-
plex (38). Both systems rely on an N-terminal sequence motif,
the presequence in mitochondria and the TonB box in bacteria,
for translocation across the OM. These sequences direct protein
import through β-barrel transporters, driven by protein com-
plexes in the IM coupled to the PMF. Unlike mitochondria,
however, where the presequence is recognized by a receptor
within the translocase, in bacteria, the imported proteins
themselves are recognized by specific receptors that also act
as translocases.
Materials and Methods
Protein Expression and Purification. His-tagged pyoS2NTD and derivatives were
expressed in BL21 (DE3) cells and were purified by nickel-affinity chroma-
tography and size-exclusion chromatography (SEC). The TonB1 periplasmic
domain (residues 109–342) was purified using the same method with the
addition of tobacco etch virus-protease removal of the His-tag. FpvAI was
expressed in E. coli TNE012 cells (ompA−, ompB−, and tsx−) (39) transformed
with pNGH183 carrying the fpvAI gene from P. aeruginosa PAO1 with an
E. coli ompF signal sequence. After isolation of the OM fraction, FpvAI was
purified by anion exchange chromatography and SEC. Details are described
in Supporting Information.
Limited Trypsin Proteolysis and Peptide Mass Fingerprinting. A total of 2 mg of
full-length pyoS2 (purified using the same method as described for the
pyoS2NTD) in a 1:1 molar complex with FpvAI was digested with 2 μg of
Sequencing Grade Modified Trypsin (Promega) at room temperature over-
night in 25 mM Tris·HCl (pH 8.0), 150 mM NaCl, and 1% (wt/vol) n-octyl-β-D-
glucopyranoside (β-OG). Digestion was stopped with 1 mM PMSF, and
fragments were copurified with FpvAI on a Superdex 200 10/300 GL column
(GE Healthcare). Fragments were resolved by SDS/PAGE, and bands were
excised for in-gel trypsin digestion and peptide mass fingerprinting as de-
scribed in Supporting Information.
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Fig. 3. Mapping the pyoS2NTD translocation pathway by photo cross-linking. (A) FRAP experiment on a P. aeruginosa PAO1 cell labeled with pyoS2NTD-GFP
demonstrates stalled import. The bleached region is highlighted (dashed circle). (Scale bar, 1 μm.) (B) Structure of the pyoS2NTD–FpvAI complex showing the
sites of pBpa incorporation in pyoS2NTD-GFP (yellow diamonds) and the major cross-link sites in FpvAI (yellow circles), most of which are located in the plug
domain of the TBDT. The red dotted line indicates the cross-link detected between pBpa184 in pyoS2NTD and Val197 in FpvAI, which requires this region of the
pyocin to translocate at least 76 Å. (C) Ten percent SDS/PAGE gel showing Coomassie-stained, in vivo cross-linked adducts of translocated pyoS2NTD-GFPpBpa
variants following purification by nickel affinity chromatography from OM extracts of P. aeruginosa PAO1 cells. Only cross-links to FpvAI were observed by LC-
MS/MS, confirming that GFP traps the translocating pyoS2NTD within FpvAI (details are provided in Materials and Methods). (D) Fragmentation spectrum of
pBpa184-Val197 cross-linked peptides (X = pBpa) with b- and y-ions indicated, along with the E-value, precursor ion mass (MH+), and precursor ion charge.
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Analytical SEC. PyoS2NTD at 5 μMwas added to a 5 μM stoichiometric complex
of FpvAI and Fe-Pvd (Sigma) in 25 mM Tris·HCl (pH 8.0), 150 mM NaCl, and
1% (wt/vol) β-OG, and was incubated at room temperature for 6 h. The
mixture was separated on a Superdex 200 10/300 GL column equilibrated in
the same reaction buffer monitoring for protein elution at A280 and for Fe-
Pvd elution at A400.
Crystallization and Structure Determination. The FpvAI–pyoS2NTD complex at
8 mg/mL, purified as described in Supporting Information, was crystallized
by the sitting-drop vapor diffusion method in 96-well MRC two-drop plates
(SWISSCI) at 18 °C. Drops consisted of 100 nL of protein and 100 nL of
crystallization solution dispensed using a Mosquito robot (TTP Labtech).
Crystals of the complex were grown in 0.35M ammonium sulfate, 13.5% (wt/vol)
PEG3350, and 0.05 M sodium acetate (pH 4.0), and were harvested after 30 d.
Crystals were cryoprotected in the crystallization solution supplemented with
1% (vol/vol) n-octyl-polyoxyethylene and 25% (vol/vol) ethylene glycol before
flash-cooling into liquid nitrogen. X-ray data were collected at the European
Synchrotron Radiation Facility on beamline ID23-2 from a single cryocooled
crystal (100 K) using a 225-mm MarMOSAIC CCD detector. Data collection,
processing, refinement, and model building are described in Supporting In-
formation. The atomic coordinates and structure factors for the pyoS2NTD
–FpvAI complex [Protein Data Bank (PDB) ID code 5ODW] have been deposited
in the PDB.
Fluorescence Microscopy.Alexa Fluor 488 was conjugated onto the C terminus
of pyoS2NTD as described in Supporting Information. P. aeruginosa PAO1 cells
were grown in M9-glucose media (6.78 g/L Na2HPO4, 3 g/L KH2PO4, 0.5 g/L
NaCl, 10 mM D-glucose, 1 mg/mL NH4Cl, 2 mM MgSO4) at 37 °C, and were
labeled with 1 μM fluorophore-conjugated pyoS2 construct for 15 min (details
are provided in Supporting Information). FRAP experiments were performed
using a PerkinElmer spinning disk confocal microscope with a 100× oil-
immersion objective (1.4 N.A.). Images were acquired using the 488-nm laser at
10% power, and bleaching was performed at 50% laser power at maximum
speed. Recovery images were acquired over a time course up to 2 min.
Bright-field images were recorded for each FRAP experiment.
ITC. For FpvAI-pyoS2NTD–binding experiments, proteins were prepared in
50 mM potassium phosphate (pH 7.0) and 1% (wt/vol) β-OG. Experiments were
performed using aMicroCal iTC200 thermostat at 25 °C. The cell contained FpvAI at
3.5 μM, and the syringe contained pyoS2NTD at 70 μM. Competition ITC experi-
ments were performed with 10 μM FpvAI and 15 μM Δ1–45 pyoS2NTD in the cell
and with 70 μMpyoS2NTD in the syringe. Because of the smallΔH, TonB1-pyoS2NTD–
binding experiments were performed using a MicroCal PEAQ-ITC isothermal ti-
tration calorimeter. Proteins were prepared in 50 mM potassium phosphate
(pH 7.0) and 150 mM NaCl. The cell contained TonB1 at 15 μM, and the syringe
contained either pyoS2NTD or Δ1–30 pyoS2NTD at 150 μM. The first injection
of 0.5 μL was followed by 19 injections of 2 μL, with each injection spaced by
180 s. Binding isotherms were fitted using the manufacturer’s software.
Growth Inhibition Assays. PyoS2 cytotoxic activity was assayed by plate-based
growth inhibition assays. Typically, a 10-mL culture of P. aeruginosa was
grown at 37 °C to an OD600 of 0.6. Lawns were prepared by addition of 200 μL
of culture to 5 mL of molten soft LB-agar [0.75% (wt/vol) agar in LB] at 42 °C
and were poured over LB-agar plates. Once set and dry, 2 μL of serially di-
luted wild-type or variant pyoS2 was applied to the lawn. Lawns were
allowed to grow overnight at 37 °C, and cytotoxicity was determined by
observation of clearance zones.
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Fig. 4. Model for pyoS2NTD translocation through FpvAI. The three-step model of pyoS2NTD translocation through FpvAI supported by pBpa cross-linking
data (Fig. 3 and Figs. S6–S9) is shown. In step 1, binding of pyoS2NTD to FpvAI mimics Fe-Pvd, activating the receptor for substrate transport and recruiting the
C-terminal domain of TonB1 in the periplasm. In step 2, a PMF-dependent mechanical force, applied via the ExbB–ExbD–TonB1 complex in the IM (not shown),
drives unfolding of the labile half of the plug domain. The N terminus of pyoS2NTD enters the ∼13-Å-wide cavity that is created, allowing it to present its own
TonB1 box in the periplasm. In step 3, the pyoS2NTD TonB1 box is bound by another copy of TonB1; at this time, the mechanical force is used to drive
translocation of pyoS2NTD through the FpvAI lumen. Further translocation is blocked by the force-resistant GFP. The multiple cross-links observed between the
labile portion of the FpvAI plug domain and translocated pyoS2NTD residues are presumed to involve unfolded polypeptide chains in the periplasm.
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LC-MS/MS Identification of in Vivo Photoactivated Cross-Links. A 500-mL cul-
ture of P. aeruginosa PAO1 was grown for 24 h at 30 °C in iron-free succinate
medium (6.1 g/L K2HPO4, 3 g/L KH2PO4, 4.1 g/L succinic acid) supplemented
with 7.5 mM (NH4)2SO4, 1 mM MgSO4, and 1× trace metal solution [prepared
as PTM4(Fe−) as described elsewhere (40)]. Cells were washed and resuspended
in 35 mL of fresh medium, incubated for 60 min in the presence of 100 nM
pyoS2NTD-GFPpBpa variants, and UV-irradiated at 365 nm for 30 min in a CL-
1000 UV cross-linker. Cells were then resuspended in 10 mM Tris·HCl (pH 8.0),
0.25% (wt/vol) lithium diiodosalicyclic acid, and 2% (vol/vol) Triton X-100, and
were lysed through sonication. The cleared lysate was ultracentrifuged at
200,000 × g for 45 min to isolate the OM fraction, which was solubilized in
10 mM Tris·HCl (pH 8.0), 5 mM EDTA, and 2% (wt/vol) β-OG. Cross-linked
complexes were purified using EDTA-resistant cOmplete His-Tag Purification
Resin (Roche) and were resolved by SDS/PAGE. Cross-linking sites weremapped
by LC-MS/MS and pLink software as described in Supporting Information.
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